by Sharon Rondeau https://www.fda.gov/vaccines-blood-biologics (Oct. 2, 2021) — Questions The Post & Email posed more than a week ago to the FDA regarding COVID-19 vaccines remain unanswered despite person-to-person contact between this writer and an FDA representative. On Wednesday, September 22, The Post & Email contacted the FDA’s Center for Biologics Evaluation and Research (CBER) […]
